Axogen, Inc. SEC filings AXGN

Axogen, Inc. has 1,000 filings in SEC EDGAR's recent list, going back to Aug 15, 2014. Its latest annual report, Form ARS, was filed on Apr 29, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Oct 28, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Oct 28, 2026 (results of operations, regulation fd disclosure). The company's fiscal year ends on December 31.

Axogen, Inc. SEC filings
Form Description Filed Period
EFFECT Filing Apr 29, 2024 —
CORRESP Letter to the SEC Apr 26, 2024 —
CORRESP Letter to the SEC Mar 29, 2024 —
UPLOAD Letter from the SEC Mar 19, 2024 —
EFFECT Filing Mar 13, 2024 —
EFFECT Filing Apr 7, 2022 —
POSASR Filing Feb 25, 2022 —
UPLOAD Letter from the SEC Jun 16, 2020 —
CORRESP Letter to the SEC May 22, 2020 —
UPLOAD Letter from the SEC Apr 27, 2020 —
CT ORDER Filing Mar 5, 2019 —
CT ORDER Filing Mar 30, 2018 —
POS EX Filing Dec 15, 2017 —
EFFECT Filing Oct 11, 2017 —
CORRESP Letter to the SEC Oct 6, 2017 —
UPLOAD Letter from the SEC Oct 4, 2017 —
CT ORDER Filing Mar 27, 2017 —
EFFECT Filing Dec 11, 2015 —
CORRESP Letter to the SEC Dec 10, 2015 —
CT ORDER Filing Dec 3, 2015 —
CT ORDER Filing Mar 31, 2015 —
CT ORDER Filing Dec 8, 2014 —

Showing 22 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Electromedical & Electrotherapeutic Apparatus (SIC 3845)
Listed as
AXGN (Nasdaq)
Fiscal year ends
December 31
Incorporated in
MN
Headquarters
Alachua, FL
SEC filer status
Large accelerated filer
SEC CIK
805928
Former names
LECTEC CORP /MN/ (until Sep 29, 2011)

Other Electromedical & Electrotherapeutic Apparatus companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.